Encompass Health CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Douglas E Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, sold 18,869 shares of common stock on August 10, 2026 for $125.38 per share.
NYSE
Mark J Tarr, President & CEO and a Director of Encompass Health Corp, sold 173,148 shares of common stock on August 10, 2026.
NYSE
John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, sold 8,906 shares of common stock on August 10, 2026 for $125.95 per share.
NYSE
Christopher R Reidy, a Director of Encompass Health Corp, reported multiple transactions in common stock on July 15, 2026.
NYSE
Edward M Christie Iii, a Director of Encompass Health Corp, reported multiple transactions in common stock on July 15, 2026.
NYSE
Terrance Williams, a Director of Encompass Health Corp, received 29 shares of common stock on July 15, 2026.
NYSE
Nancy M Schlichting, a Director of Encompass Health Corp, received 40 shares of common stock on July 15, 2026.
NYSE
Kevin J. O'Connor, a Director of Encompass Health Corp, received 19 shares of common stock on July 15, 2026.
NYSE
Leslye G Katz, a Director of Encompass Health Corp, received 85 shares of common stock on July 15, 2026.
NYSE
Joan E Herman, a Director of Encompass Health Corp, received 85 shares of common stock on July 15, 2026.
NYSE
Cain A Hayes, a Director of Encompass Health Corp, received 4 shares of common stock on July 15, 2026.
NYSE
Greg D Carmichael, a Director of Encompass Health Corp, received 29 shares of common stock on July 15, 2026.
NYSE
Encompass Health Corp. EVP & CFO Douglas E. Coltharp reported transactions involving company stock, including the acquisition of shares via options and subsequent sales.
NYSE
Encompass Health Corp. reports a stock transaction by EVP, Chief Operating Officer Patrick William Tuer.
NYSE
Encompass Health Corp. director Kevin J. O'Connor acquired 1,634 shares of common stock through an annual restricted stock unit grant.
NYSE
Encompass Health Corp. director Edward M. Christie III acquired 1,634 restricted stock units as part of an annual grant.
NYSE
Encompass Health Corp. reports that Director Christopher R. Reidy acquired 1,634 restricted stock units under the company's 2025 Omnibus Performance Incentive Plan.
NYSE
Encompass Health Corp. director Cain A. Hayes was granted restricted stock units as part of an annual incentive plan.
NYSE
Encompass Health Corp. reports a Form 4 filing detailing a stock acquisition by Director Greg D. Carmichael.
NYSE
Encompass Health Corp. director Terrance Williams acquired 1,634 shares of common stock through an annual restricted stock unit grant.
NYSE
Encompass Health Corp. reports a Form 4 filing detailing a stock acquisition by Director Leslye G. Katz.
NYSE
Encompass Health Corp. director Joan E. Herman acquired 1,634 shares of common stock through an annual grant of restricted stock units.
NYSE
Encompass Health Corp. director Nancy M. Schlichting was granted 1,634 restricted stock units as part of an annual award.
NYSE
Director Greg D. Carmichael acquired 27 restricted stock units in Encompass Health Corp via dividend reinvestment.
NYSE
Director Edward M. Christie III acquired additional Encompass Health Corp shares through dividend reinvestment and fee deferral.
NYSE
Director Cain A. Hayes acquired 1 restricted stock unit in Encompass Health Corp via a dividend reinvestment mechanism.
NYSE
Director Joan E. Herman acquired 85 restricted stock units as part of a dividend reinvestment program.
NYSE
Director Leslye G. Katz acquired 85 restricted stock units of Encompass Health Corp via dividend reinvestment.
NYSE
Director Kevin J. O'Connor acquired 17 restricted stock units as part of a dividend reinvestment program.
NYSE
Director Christopher R. Reidy acquired additional Encompass Health common stock through dividend reinvestment and a deferred compensation plan.